Orthopediatrics

Q2 FY2026 EarningsQ2 FY26 results exceeded consensus on the top line, with revenue of $70.5M beating the $68.2M estimate. Gross margin came in at 74.3%, significantly higher than the 72.7% expected, driven by strength in the Trauma and Deformity segment and clinic expansions. Despite the revenue beat, GAAP EPS of -$0.30 slightly missed the -$0.29 consensus due to higher interest expenses and foreign exchange headwinds. Management continues to leverage strategic acquisitions and the Braidwell credit facility to support inventory expansion and global growth.